medmix Past Earnings Performance

Past criteria checks 0/6

medmix's earnings have been declining at an average annual rate of -31.9%, while the Medical Equipment industry saw earnings growing at 7.6% annually. Revenues have been growing at an average rate of 3.9% per year. medmix's return on equity is 0.1%, and it has net margins of 0.06%.

Key information

-31.9%

Earnings growth rate

-39.6%

EPS growth rate

Medical Equipment Industry Growth11.1%
Revenue growth rate3.9%
Return on equity0.1%
Net Margin0.06%
Next Earnings Update18 Jul 2024

Recent past performance updates

There May Be Reason For Hope In medmix's (VTX:MEDX) Disappointing Earnings

Feb 28
There May Be Reason For Hope In medmix's (VTX:MEDX) Disappointing Earnings

Recent updates

medmix (VTX:MEDX) Is Reinvesting At Lower Rates Of Return

Dec 19
medmix (VTX:MEDX) Is Reinvesting At Lower Rates Of Return

An Intrinsic Calculation For medmix AG (VTX:MEDX) Suggests It's 21% Undervalued

Oct 27
An Intrinsic Calculation For medmix AG (VTX:MEDX) Suggests It's 21% Undervalued

Investors Could Be Concerned With medmix's (VTX:MEDX) Returns On Capital

Aug 16
Investors Could Be Concerned With medmix's (VTX:MEDX) Returns On Capital

There May Be Reason For Hope In medmix's (VTX:MEDX) Disappointing Earnings

Feb 28
There May Be Reason For Hope In medmix's (VTX:MEDX) Disappointing Earnings

medmix (VTX:MEDX) May Have Issues Allocating Its Capital

Jan 14
medmix (VTX:MEDX) May Have Issues Allocating Its Capital

Revenue & Expenses Breakdown
Beta

How medmix makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SWX:MEDX Revenue, expenses and earnings (CHF Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 23487011926
30 Sep 23481511325
30 Jun 234751010824
31 Mar 234761110524
31 Dec 224771210324
30 Sep 224782110223
30 Jun 224803110123
31 Mar 22468379823
31 Dec 21457449623
30 Sep 21435369223
30 Jun 21414288923
31 Mar 21382198522
31 Dec 20351108120
31 Dec 19421258623
31 Dec 18454528523

Quality Earnings: MEDX has a large one-off loss of CHF1.9M impacting its last 12 months of financial results to 31st December, 2023.

Growing Profit Margin: MEDX's current net profit margins (0.06%) are lower than last year (2.4%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: MEDX's earnings have declined by 31.9% per year over the past 5 years.

Accelerating Growth: MEDX's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: MEDX had negative earnings growth (-97.4%) over the past year, making it difficult to compare to the Medical Equipment industry average (-7.1%).


Return on Equity

High ROE: MEDX's Return on Equity (0.1%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.